RTTNews | Jul 17, 2020 10:23AM EDT

10:23 Friday, July 17, 2020 (RTTNews.com) - Shares of Checkpoint Therapeutics, Inc. (CKPT) are currently gaining nearly 45% on Friday morning despite no stock-specific news to drive the shares. Most of the US stocks are trading higher today as investors are optimistic going forward driven by the promising study results of COVID-19 vaccine.

CKPT is currently trading at $2.42, up $0.75 or 44.91%, on the Nasdaq.

Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company, which focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's product candidates include CK-101 that in Phase I clinical trial for the treatment of epidermal growth factor receptor mutation-positive non-small cell lung cancer; and Cosibelimab, a programmed death ligand-1, which is in Phase I clinical trial in patients with selected recurrent or metastatic cancers.

Read the original article on RTTNews ( https://www.rttnews.com/3112066/stock-alert-checkpoint-therapeutics-ckpt-up-45.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved